However, depending on molecular features, aberration profiles, and the diagnostic subvariant of AML, LSC are also detectable in a (phenotypically) more mature CD34+/CD38+ subset or even in CD34‐negative AML cell subsets.20, 21. This evidence concerns the gene CD34 and acute myeloid leukemia.